📰 Use Listing News
Page 12 - Use Listing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Listing. Real-time updates on events, politics, business and more.
December 20, 2021
An opened vial of Covid-19 vaccine Covaxin can be stored at 2 to 8 degrees Celsius for up to 28 days and is not required to be discarded immediately in a day or at the end of immunisation session, Bharat Biotech said on Monday.
December 18, 2021
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by volume, today announced that the World Health Organization (WHO) has granted Emergency Use Listing (EUL) for NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant, for active immunization of individuals 18 yea...
December 17, 2021
First EUL granted by WHO for a protein-based COVID-19 vaccine EUL vaccine manufactured and marketed by SII as COVOVAX WHO EUL for Nuvaxovid currently under assessment; will be completed
December 17, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 17, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
December 17, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 17, 2021
First EUL granted by WHO for a protein-based COVID-19 vaccine EUL vaccine manufactured and marketed by SII as COVOVAX™ WHO EUL for Nuvaxovid™ currently under assessment; will be... | December 17, 2021
December 17, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 17, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 17, 2021
Covovax, emergency use approval, covovax, covid vaccine, covid 19, vaccine, omicron, omicron vaccine efficiancy, Serum Institute of India, WHO approved, who news, omicron, covid 19 cases india, covid 19 cases, omicron cases india, omicron india